Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Operating Expenses | 1,874 | 1,993 | 2,056 | 1,896 | 1,704 |
| Operating Income | -1,874 | -1,993 | -2,056 | -1,896 | -1,704 |
| Other Income | 0 | 0 | -129 | -345 | 0 |
| Pre-tax Income | -1,874 | -1,993 | -2,185 | -2,242 | -1,704 |
| Net Income Continuous | -1,874 | -1,993 | -2,185 | -2,242 | -1,704 |
| Net Income | $-1,874 | $-1,993 | $-2,185 | $-2,242 | $-1,704 |
| EPS Basic Total Ops | -127.14 | 63.87 | -31.63 | -115.74 | -80.96 |
| EPS Basic Continuous Ops | -127.16 | 41.54 | -31.67 | -53.94 | -80.82 |
| EPS Diluted Total Ops | -127.14 | 63.87 | -31.63 | -115.74 | -80.96 |
| EPS Diluted Continuous Ops | -127.16 | 41.54 | -31.67 | -53.94 | -80.82 |
| EBITDA(a) | $-1,867 | $-1,967 | $-2,027 | $-1,863 | $-1,664 |